Displaying 121 - 130 of 604
Blood Cancer Day 2025 at University of Toronto's Faculty of Pharmacy
Updated:
The LLSC was invited to present at Blood Cancer Day on Saturday, May 3, 2025 at the University of Toronto Leslie Dan Faculty of Pharmacy.
Events, Partners
One Kilometre at a Time transportation subsidy program
Updated:
The One Kilometre at a Time transportation subsidy from the Leukemia and Lymphoma Society of Canada provides one-time financial support to Canadians with an acute or chronic blood cancer requiring at least 30 km round trip for medical appointment(s) as referred by their…
Who we are
Updated:
We won’t stop until there is a cure for leukemia, lymphoma, myeloma, myelodysplastic syndromes and myeloproliferative neoplasms and are able to improve the quality of life of people affected by blood cancers and their families by funding life-enhancing research and providing…
CLL Live 2025: All things chronic lymphocytic leukemia
Updated:
CLL is one of the most common types of leukemia in adults; CLL Canada holds it free annual conference for patients by patients.
Events, Partners
Multiple Myeloma
Updated:
Learn more about multiple myeloma and the resources we have available.
Myeloma
Image
Understanding multiple myeloma
Updated:
Multiple myeloma, or MM, is a type of blood cancer that starts in the bone marrow. Multiple myeloma affects plasma cells, a type of white blood cell that normally fights infection, turning healthy cells into cancer cells that can damage blood, bones and kidneys.
Myeloma
Canadian Association of Psychosocial Oncology (CAPO) 2025: Care of the soul in cancer
Updated:
LLSC was delighted to have the opportunity to participate again in the annual conference of the Canadian Association of Psychosocial Oncology (CAPO), in Toronto April 2025.
Events, Partners
Barry Yhard: First Connection Volunteer of the Year 2025
Updated:
Diagnosed with Hodgkin’s Lymphoma in 2015, Barry Yhard decided as a survivor to become a First Connection peer support volunteer at LLSC.
Volunteers
Addressing the global Pegasys® shortage
Updated:
Following Health Canada’s decision to grant ropeginterferon (BESREMi®) exceptional importation status, some of the provinces and private insurance plans have been starting to cover BESREMi® treatment. Work is continuing in the provinces where there is not yet coverage.
Advocacy, Partners, Myeloproliferative neoplasms